Fundraising Fox

NeuroVasc

California, US · Founded 2015 · Delaware corporation · 2 known investors

neurovasctechnologies.com

NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.

Deep TechHealthtechMedical Devicesin /neurovasc-technologies-inc

Founders & leadership

JP
JEFF PETERSDirector
LG
LU GANGDirector
DF
DAVE FERRERADirector
JM
JIANLU MAExecutive Officer, Director
WD
WILLIAM DAIDirector

Investors · 2

Competitors · 9

by search overlap
Evtoday31 shared keywords
Innova Vascular26 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Massdevice25 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Diabetes Prevention Program24 shared keywords
Read the Press Release21 shared keywords
Fda19 shared keywords
Boston Scientific19 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Vantis Vascular17 shared keywordsVantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter> <parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter> <parameter name="hq_city">San Jose
EndoSense16 shared keywords

Companies competing with NeuroVasc for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$4.2MraisedMay 2018 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jianlu MaExecutive Officer, Director
  • James HanDirector
  • Michael LosordoExecutive Officer
  • William DaiDirector
  • Gang LuDirector
Offering amount
$6.4M
Amount sold
$4.2M
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$500KraisedNov 2017 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JIANLU MaExecutive Officer, Director
  • Gang LuDirector
  • William DaiDirector
Offering amount
$900K
Amount sold
$500K
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedDec 2016 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gang LuDirector
  • William DaiDirector
  • Jeff PetersDirector
  • JIANLU MaExecutive Officer, Director
Offering amount
$1M
Amount sold
$1M
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.4MraisedNov 2015 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFF PETERSDirector
  • LU GANGDirector
  • DAVE FERRERADirector
  • WILLIAM DAIDirector
  • JIANLU MAExecutive Officer, Director
Offering amount
$2.7M
Amount sold
$1.4M
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news